Importantly, CDC20 upregulation is associated with several types of cancer including breast and colon cancer and has been involved in aggressive tumor progression and poor prognosis in gastric cancer and primary non-small cell lung cancer [72]. This evidence concerns the gene CDC20 and non-small cell lung carcinoma.